Citizens JMP analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $38 from $36 and keeps an Outperform rating on the shares following the Q2 report. The firm upped estimates and remains constructive on the shares citing the company’s consistent execution and its expectations for continued share gains.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPCH:
- Option Care Health Reports Strong Q2 2025 Results
- Option Care Health’s Earnings Call Highlights Robust Growth
- Option Care Health: Strong Financial Performance and Positive Outlook Justify Buy Rating
- Option Care Health sees FY25 adjusted EPS $1.65-$1.72, consensus $1.68
- Option Care Health reports Q2 adjusted EPS 41c, consensus 40c